Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05096390
Title Axitinib +/- Pembrolizumab in First Line Treatment of mPRCC (PAXIPEM)
Acronym PAXIPEM
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Leon Berard
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Ico - Paul Papin NOT_YET_RECRUITING Angers 49055 France Details
CHU de BESANCON NOT_YET_RECRUITING Besançon 25030 France Details
Chu Bordeaux RECRUITING Bordeaux 33000 France Details
Centre Jean Perrin NOT_YET_RECRUITING Clermont-Ferrand 63011 France Details
Centre Leon Berard RECRUITING Lyon 69008 France Details
Institut Paoli-Calmettes RECRUITING Marseille 13009 France Details
Centre Antoine Lacassagne RECRUITING Nice 06189 France Details
Ap-Hp Hôpital Europeen Georges Pompidou NOT_YET_RECRUITING Paris 75004 France Details
Ico-Rene Gauducheau NOT_YET_RECRUITING Saint-Herblain 44805 France Details
Iuct-Oncopole Institut Claudius Regaud RECRUITING Toulouse 31059 France Details
Institut de Cancerologie de Lorraine - Alexis Vautrin RECRUITING Vandœuvre-lès-Nancy 54519 France Details
Gustave Roussy RECRUITING Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field